A91 Partners’ spinout from Sequoia Capital showcases the deepening networks of the Indian VC space and hints that more ecosystem growth is yet to come
By the time Abhay Pandey, Gautam Mago and V.T. Bharadwaj, all managing directors at Sequoia Capital India, spun out from the VC giant earlier this year, they had been working together for more than 15...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.